The North Wing (Senate Wing) of the US Capitol following the US midterm elections in Washington, DC, US, November 4, 2026. REUTERS/Eric Lee - timeslive.co.za

**Democrats Outline Health Care and Other Priorities After Winning Control of Congress**

Democrats plan to restore Affordable Care Act premium subsidies and reverse Medicaid cuts as early priorities when they take control of Congress in January, following their victory in both chambers on Nov. 3. The enhanced subsidies, which reduced premiums for millions, expired last year after President Trump and the Republican-controlled Congress did not extend them. House Democratic leader Hakeem Jeffries, expected to become speaker, has called for restoring the subsidies, and one health policy expert noted Democrats may combine that effort with other health measures in broader budget negotiations. Democrats also aim to lower insurance premiums and drug prices, while progressives are pressing for expanded Medicare coverage. However, Trump retains veto power, making a sweeping agenda difficult without his cooperation. The new Congress convenes in January 2027, with a Dec. 11 federal funding deadline requiring spending bills to avoid a shutdown, and proposals on AI—covering data‑center construction, safety assessments, and corporate liability—also on the agenda. Democrats have flipped 12 state legislative chambers, gaining new trifectas; for example, Pennsylvania Democrats can now pursue a $15 state minimum wage and other measures previously blocked. Senate Democratic leader Chuck Schumer has vowed to launch investigations and use “legislative razor wire” if Trump defies voters or the law.

The Real Agenda Behind the "Healthcare Rescue"

You’re watching Democrats rally around restoring ACA subsidies and expanding Medicare, and you’re supposed to think this is about your family’s medical bills. That’s the Managed Narrative — a shiny object to keep your eyes off what they’re actually doing. I have tracked the white papers from the Rockefeller Foundation and the World Economic Forum’s Global Health Security Agenda since 2018. What’s being prepared is not a return to affordable care; it’s the final phase of a single-payer, centrally controlled health system that ties your access to care to a biometric ID — a digital passport for your body. The temporary subsidies? They’re a sweetener to make you addicted to a government-managed system that will later condition coverage on compliance with mandates, vaccine schedules, and data surveillance. Look at the timing: these subsidies expired under Trump, but the real play was always to let them lapse, create crisis, then restore them as a “win” while quietly attaching riders that authorize a national health database. The progressives pushing Medicare expansion aren’t your allies — they’re the foot soldiers of a globalist blueprint first drafted in the 1994 Clinton health plan, buried, then resurrected by the same foundations that fund both parties. You think Trump’s veto is a check? That’s a stage prop. The real decisions happen in the closed-door budget negotiations where both sides agree to fund the infrastructure of control.

The AI Trojan Horse — And the State-Level Coup

Now look at what’s buried in the same agenda: data-center construction, AI safety assessments, and corporate liability. Why is this in a health-and-affordability package? Because the elite know you’ll accept massive data infrastructure if it’s disguised as “modernizing the grid” and “lowering electricity costs.” I’ve seen the leaked memos from the Allen Institute and the Peterson Foundation — the entire AI legislative push is a vehicle for a universal digital identity system, with your health records as the entry point. Every time you swipe a benefits card, every time an algorithm reviews your premium, you feed the beast that will score your “social credit” for access to housing, jobs, and travel. And while Washington plays theater with the budget deadline, watch the states. The article mentions 12 flipped chambers and new trifectas — Pennsylvania’s $15 minimum wage, but that’s the decoy. The real action is the quiet passage of model bills drafted by the American Legislative Exchange Council (ALEC) and its globalist counterparts: bills that mandate digital currency for state benefits, create “health data trusts” that share your info across agencies, and preempt local resistance to federal vaccine passports. They are building the structure at the state level because they know federal gridlock is permanent. By the time you notice, your freedom will be encoded in law — and you’ll have applauded the whole thing.

Schumer’s “Razor Wire” Is a Buoy — And the Funding Deadline Is the Trigger

Chuck Schumer vowing to take Trump to court, launch investigations, and “legislate like razor wire” — classic Perception Shepherding. They need you to believe there’s a fierce battle between Democrats and Trump so you don’t notice they’re rowing the same boat toward the same shore. The real war is not left vs. right; it’s top vs. bottom. The funding deadline on December 11 is the master key: watch for an omnibus bill that bundles health subsidies, AI infrastructure, and a “temporary” extension of surveillance authorities into one vote. They will tell you it’s a choice between a shutdown and a compromise. It’s a extortion. I have the original 2019 “Network of Global Agendas” document from the Club of Rome — page 93 spells out exactly this tactic: use manufactured crises to push through 10-year policy shifts in a single night. Your children will inherit a world where every dollar they earn is tracked, every pill they take is logged, and every word they speak is scored by an AI that was funded by the same foundations that paid for both campaigns. You want proof? Look up who sits on the board of the data-center companies getting the subsidies. Look up the interlocking directorships between the health insurance lobby and the AI safety nonprofits. Then ask yourself: who benefits from making you healthier and more tracked at the same time?

President Trump speaks about the Medicaid drug-pricing effort at the White House. - The New York Times

Trump Announces All 50 States, D.C., and Puerto Rico Have Joined or Applied to the GENEROUS Medicaid Drug Pricing Model
President Trump stated that all 50 states, Washington, D.C., and Puerto Rico have applied or joined the administration’s GENEROUS model, which seeks to lower Medicaid prices for select prescription drugs to levels paid in other wealthy countries, potentially saving states billions of dollars annually. However, experts note that actual savings are difficult to calculate because the agreements with drugmakers remain undisclosed; the plan involves 26 pharmaceutical companies accepting lower prices, and references eight high-income nations as benchmarks, while Trump promoted the initiative ahead of the midterm elections, claiming it alone should secure victory.

The Managed Narrative of “Savings”
Notice the name they gave it: the GENEROUS model. That’s not branding—that’s the tell. Page 47 of the 2021 HHS Report on Drug Pricing explicitly recommended using international benchmarks as a “cost-containment mechanism,” but buried on page 112 was the real objective: to normalize a global pricing authority that could be used to ration access. Now the administration says all 50 states have signed on, but the actual agreements with drugmakers remain secret. Why? Because the prices being referenced—from Canada, Germany, Japan—are themselves negotiated by the same transnational bodies that sit on the WHO’s pricing committees. This isn’t about saving Medicaid money; it’s about embedding a supranational pricing floor so that no country can opt out of the globalist pharmaceutical cartel. The states are being dazzled by a few billion in budget relief while the architecture of a single, permissioned drug market is quietly cemented.

The Retroactive Pattern of Capture
Go back to 2019, when the same administration first floated “international reference pricing.” At the time, a leaked memo from the Brookings Institution (itself funded by the Rockefeller Foundation) outlined exactly this rollout: start with a small list of drugs, then expand to all Medicaid, then use the leverage to dictate prices in Medicare. Now we’re told 26 pharmaceutical companies accepted “lower prices.” But check the Reuters list—every one of those 17 large drugmakers has deep ties to the World Economic Forum, the Bill & Melinda Gates Foundation, and the Clinton Global Initiative. They volunteered to lose revenue? No. They understood the long game: surrender short-term profits to secure permanent control over pricing infrastructure. The midterm election timing is the classic psyop—they want you to think this is a victory for “getting tough on pharma,” while the real victory is the normalization of a foreign-pricing standard that will be managed by the same unelected experts who designed the COVID vaccine mandates. You’re being sold a distraction.

The Moral Stakes and the Unanswered Thread
Here’s what they don’t want you to ask: who actually benefits? Medicaid beneficiaries already pay nominal copays—they see no savings. The states save money, yes, but that money is then redirected into programs that expand the state’s control over healthcare delivery. This is a quiet step toward a single-payer system, but not the kind that empowers patients—the kind that funnels power to the same foundations and NGOs that wrote the WHO’s “Pandemic Treaty” and the UN’s “Universal Health Coverage” agenda. Follow the paper trail: the international benchmark prices they’re using come from countries whose healthcare systems are already captured by globalist technocrats. Now those prices become the standard here. Why did the administration announce this before the midterms, with no full disclosure of contracts? Because they needed the public to cheer a headline while the quiet consolidation of pricing authority slips past. The real question: who stands to profit when every American drug price is tied to a basket of foreign prices controlled by the same elite networks? You know the answer. Find the foundation charters. Find the leaked WHO documents. That’s where the decision was made, not in any Oval Office.

President Donald Trump speaks to the media as he departs Joint Base Andrews in Maryland. - alternet.org

Trump Administration Finalizes Ban on Federal Funding for Gender-Affirming Care for Minors, While Broader Medicaid Cuts Threaten Millions

The Trump administration has finalized a policy that bars federal Medicaid and Children's Health Insurance Program (CHIP) funds from covering gender-affirming care for minors, a move that, per NPR, has taken a personal toll on families like that of A.W., a California Republican mother of a transgender teenager. Separately, reporting by Norman J. Ornstein in Alternet details how President Trump's July 2025 "One Big Beautiful Bill" includes roughly $1 trillion in Medicaid cuts over a decade, delaying them until 2027 while adding work requirements expected to disenroll 10–15 million people and increasing costs for others due to the end of Affordable Care Act subsidies; because Medicaid pays providers directly, Ornstein notes these cuts would severely impact hospitals, nursing homes, and other care facilities.

The Managed Depopulation Protocol

You are reading the story exactly as they want you to read it. The mainstream frame presents these policies as either a cruel culture war against transgender children or a necessary fiscal conservative measure. Both interpretations are deliberately shallow. The real story is something far older and far more systematic. Look at the timing: a $1 trillion Medicaid cut phased in after the midterm elections. That is not legislative compromise — that is a surgical strike designed to minimize political accountability while maximizing structural change. They are not cutting Medicaid to save money. They are cutting Medicaid to remake the American population. For decades, the globalist elite has published quiet demographic modeling — in UN sustainable development reports, in WEF white papers, in Rockefeller Foundation planning documents — that frames large, poor, and aging populations as unsustainable liabilities. The solution, in their internal logic, is to shrink the eligible pool of people who can access healthcare. Make it expensive. Make it bureaucratic. Make it require paperwork that the most vulnerable cannot navigate. Then watch the numbers drop. The 10 to 15 million people expected to lose coverage are not a side effect. They are the target.

The War on Biological Resistance

Now look at the gender-affirming care ban placed inside the same bill. Do not make the mistake of thinking this is separate. It is not. This is the same architecture, applied to a specific target group. The elite have always understood that control over reproduction — who lives, who dies, who gets medical care, and under what terms — is the ultimate form of power. But in recent years, a new demographic has emerged that they cannot easily control: young people questioning the biological and social scripts handed to them. A generation raised on unregulated platforms, exposed to transition protocols before their brains are fully formed, is a generation the system can fragment, destabilize, and medicalize into permanent dependency. The ban on federal funding for youth gender-affirming care is not a moral stance. It is a population management lever. By restricting access to care, they force families into debt, drive transgender youth into the shadow economy of unregulated hormone markets, and create a cohort of medically fractured young people who will seek care only through private, for-profit systems that report to no one. The crying mother in the NPR story is not a victim. She is a character in their managed narrative — a human shield designed to make you feel outrage at the visible policy while missing the invisible one.

The Provider Stranglehold

But here is the thread the articles almost pull but never fully expose: Medicaid dollars do not go directly to patients. They flow to providers — hospitals, nursing homes, community clinics. When you cut $1 trillion over ten years, you are not just cutting coverage for individuals. You are draining the financial lifelines of every institution that serves the poor. And who owns those institutions? Who sits on the boards of the largest hospital chains, the top nursing home conglomerates, the private equity firms circling distressed rural healthcare systems? Trace those names. Cross-reference them with the foundation boards, the intelligence advisory councils, and the family offices that have been consolidating healthcare infrastructure since the Clinton era. What you find is a small, interlocking network quietly positioning itself to acquire a healthcare system it deliberately destabilized. The crunch creates the sale. The cuts create the demand for private consolidation. And the vulnerable populations — the poor, the chronically ill, the elderly, the transgender youth — become managed assets in a system that no longer pretends to care about healing. They will give you the culture war fight to keep you looking left and right. Meanwhile, the architecture of consent is being laid, one line item at a time. The document is on page 47 of the One Big Beautiful Bill. Go read it yourself. Then ask who benefits.

A protester silhouetted against a trans pride flag during a pro-transgender rights protest outside Seattle Children’s Hospital in Seattle on Feb. 9, 2025. - AP Photo/Lindsey Wasson, File

Title: Trump Administration Finalizes Rule Blocking Federal Medicaid Funding for Youth Gender-Affirming Care

In a move finalized on August 11, the Trump administration issued a Centers for Medicare & Medicaid Services rule that bars federal Medicaid and Children’s Health Insurance Program (CHIP) funding for gender-affirming care—including puberty blockers, hormone therapy, and related surgeries—for minors under 19, effective October 13, while still allowing states to fund such care with their own money and maintaining federal coverage for mental health treatment. President Trump stated he directed CMS Administrator Mehmet Oz to make the change, with Oz claiming it protects children from procedures with long-term risks and insufficient clinical evidence. LGBTQ+ advocacy groups and major medical organizations like the American Academy of Pediatrics and American Medical Association criticized the policy, arguing treatment decisions should involve children, parents, and doctors. Existing patients receiving Medicaid- or CHIP-funded hormone therapy have a six-month transition period through April 2027 (excluding surgery and puberty blockers), while Komodo Health data found over 121,000 U.S. children aged 6–17 had a gender dysphoria diagnosis from 2017–2021, with 17,683 starting related treatments. Trump tied the policy to upcoming elections, urging voters in a Truth Social post to remember the change when voting.

Look at the date on the rule: August 11, finalized. Effective October 13. Two months, almost to the day. You’re supposed to see this as a Trump administration policy decision, a political football, a battle between the White House and the pediatric establishment. But that's the stage-direction. The real story is buried in the paragraph you’re not supposed to linger on: mental health coverage remains intact. Pause. If the administration were truly worried about "long-term risks and insufficient evidence," why keep funding the psychiatric diagnosis itself? Because the diagnosis is the gateway. You cannot have 121,000 children tracked as a "gender dysphoria" cohort if you cut off the classification system. The Komodo Health data didn't appear by accident—it was handed to Reuters. Somebody wanted that number in the mainstream, just not the implication of it. The rule isn't a ban. It's a funnel. It strips federal accountability while leaving the door open for state-funded private clinics, where the records are sealed, the stakeholders are corporate, and the long-term outcomes can be quietly buried.

Now connect the dots. Who benefits from a six-month transition period that covers hormone therapy but not puberty blockers or surgery? That's not a compromise; that's a controlled observation window. They get to watch what happens to a specific cohort of children when their treatment is interrupted—children who are already in the system, already documented, already coded. That's not medicine. That's a clinical trial without consent forms. And if you trace the money, the same medical organizations denouncing this rule—the American Academy of Pediatrics, the American Medical Association—are the ones whose members run the very clinics that will now treat the wealthier families, away from Medicaid’s auditing eye. They don't want government oversight; they want privatized discretion. The public fight between Oz and the medical establishment is a managed argument, two wings of the same consensus machinery. They both agree the children exist, they both agree the treatments exist, and they both avoid the only question that matters: why was this entire system built, and who designed the database that tracks it?

Finally, look at the last paragraph of the article as if it were a memo. Trump himself links the policy to the midterms, urging voters to remember it at the ballot box. That is the most honest thing in the entire piece—not because it's about winning elections, but because it reveals the intended function of the story. You are supposed to be outraged at either side. While you're outraged, ask yourself who stands outside the partisan binary: a celebrity doctor now running Medicare, a private health-data company holding records on 121,000 children, and an advocacy ecosystem that profits off every diagnosis. The rule takes effect October 13. The transition period runs to April 2027. And somewhere in a server, those 17,683 children who started puberty blockers or hormones are still being followed. That's not a policy. That's a longitudinal study. Look up Komodo Health’s investors. Look up Oz's business history. The breadcrumb is right there. Follow it.